Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
21.96
+0.10 (0.48%)
Dec 24, 2025, 1:00 PM EST - Market closed
0.48% (1D)
| Assets | $15.44M |
| Expense Ratio | 0.55% |
| PE Ratio | 18.53 |
| Shares Out | 700,000 |
| Dividend (ttm) | $0.06 |
| Dividend Yield | 0.28% |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 5.18% |
| Volume | 142 |
| Open | 21.96 |
| Previous Close | 21.86 |
| Day's Range | 21.96 - 21.96 |
| 52-Week Low | 15.37 |
| 52-Week High | 22.18 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
21.47% of assets| Name | Symbol | Weight |
|---|---|---|
| UiPath Inc. | PATH | 2.26% |
| Enphase Energy, Inc. | ENPH | 2.19% |
| BioMarin Pharmaceutical Inc. | BMRN | 2.17% |
| Nutanix, Inc. | NTNX | 2.14% |
| Twilio Inc. | TWLO | 2.14% |
| Expedia Group, Inc. | EXPE | 2.14% |
| F5, Inc. | FFIV | 2.13% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.12% |
| Bristol-Myers Squibb Company | BMY | 2.10% |
| Maplebear Inc. | CART | 2.09% |
